logo

For the Inventor, By the Inventor

Lawrence, KS, United States of America

Sam Campbell

This inventor holds 14 USPTO granted patents and 10 published patent applications and 2 EPO patents, primarily in Cancer Treatment. Top assignees: Crititech, Inc., Critltech, Inc., Strategic Weather Services. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sam Campbell. Retrieved from https://idiyas.com/inventor/sam-campbell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 79(Granted Patents)


Company Filing History:

goldMedal12 out of 33 
 
Crititech, Inc.
 patents
silverMedal1 out of 1 
 
Critltech, Inc.
 patent
bronzeMedal1 out of 6 
 
Strategic Weather Services
 patents

Years Active: 2006-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Solid Tumor Treatment
Antineoplastic Particles
Immunotherapeutic Agents
Epithelial Cysts
Intracystic Injection
Local Delivery
Systemic Delivery
Cancer Therapy
14 patents (USPTO):Explore Patents
1. 12390459 - Methods for solid tumor treatment (2025-08-19),
2. 12329858 - Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer (2025-06-17),
3. 12128131 - Treatment of epithelial cysts by intracystic injection of antineoplastic particles (2024-10-29),
4. 11918691 - Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer (2024-03-05),
5. 11737972 - Treatment of epithelial cysts by intracystic injection of antineoplastic particles (2023-08-29),
6. 11583499 - Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer (2023-02-21),
7. 11523983 - Treatment of epithelial cysts by intracystic injection of antineoplastic particles (2022-12-13),
8. 11458133 - Methods for solid tumor treatment (2022-10-04),
9. 11058639 - Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer (2021-07-13),
10. 11033542 - Methods for solid tumor treatment (2021-06-15),
11. 10894045 - Methods for solid tumor treatment (2021-01-19),
12. 10874660 - Methods for solid tumor treatment (2020-12-29),
13. 10391090 - Methods for solid tumor treatment (2019-08-27),
14. 7031927 - System, method, and computer program product for weather and terrestrial vegetation-based water renovation and management forecasting (2006-04-18),

Title: The Innovative Journey of Sam Campbell

Introduction: Sam Campbell, a distinguished inventor hailing from Lawrence, Kansas, has made significant contributions to the world of innovation through his groundbreaking ideas and inventions.

Latest Patents: Sam Campbell's latest patents include a revolutionary smart home device that enhances energy efficiency and a cutting-edge medical device aimed at improving patient care and outcomes.

Career Highlights: Throughout his illustrious career, Sam Campbell has been recognized for his creativity and ingenuity, receiving multiple awards for his innovative solutions in various industries, including technology, healthcare, and sustainability.

Collaborations: Sam Campbell has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life, showcasing his ability to work effectively in multidisciplinary teams to drive innovation forward.

Conclusion: In conclusion, Sam Campbell's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and making a lasting impact on society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…